Periarteritis Nodosa: Causes, Symptoms & Treatment

Periarteritis nodosa, also known as polyarteritis nodosa (PAN), is a rare, systemic form of vasculitis characterized by inflammation and necrosis of medium-sized and small arteries. This multisystem disease can affect various organs and tissues throughout the body, leading to a wide range of symptoms and potential complications.

Definition and Classification

Polyarteritis nodosa is classified as a necrotizing vasculitis, a group of disorders that involve inflammation and damage to blood vessel walls. It primarily affects medium-sized and small arteries, leading to the development of aneurysms, stenosis, and occlusions. PAN is a systemic condition, meaning it can impact multiple organs and systems throughout the body.

Source: Polyarteritis Nodosa – StatPearls – NCBI Bookshelf

Epidemiology

Periarteritis nodosa is a rare disease, with an estimated incidence of 2 to 9 cases per million people annually. It can affect individuals of any age or gender, but it is more commonly seen in adults between the ages of 40 and 60 years. The condition has been reported in various geographic regions, but it appears to be more prevalent in certain areas, such as Europe and North America.

Source: Epidemiology and Pathogenesis of Polyarteritis Nodosa – PMC

Pathophysiology

The pathophysiology of periarteritis nodosa involves the inflammation and necrosis of blood vessel walls, particularly the medium-sized and small arteries. The exact mechanisms underlying this vascular injury are not fully understood, but it is believed to involve an autoimmune response and the formation of immune complexes that deposit in the vessel walls, triggering inflammation and subsequent tissue damage.

Source: Polyarteritis Nodosa – StatPearls – NCBI Bookshelf

Etiology and Risk Factors

The precise cause of periarteritis nodosa remains unknown, but several factors have been implicated in its development. These include:

• Genetic predisposition: Certain genetic factors may increase an individual’s susceptibility to developing PAN.
• Environmental triggers: Exposure to certain toxins, chemicals, or infectious agents may contribute to the development of the disease.
• Autoimmune mechanisms: Autoimmune processes, where the body’s immune system mistakenly attacks its own tissues, are thought to play a role in the disease pathogenesis.

Source: Epidemiology and Pathogenesis of Polyarteritis Nodosa – PMC

Clinical Presentation

Periarteritis nodosa can present with a wide range of symptoms due to its systemic nature and the involvement of multiple organ systems. Some common signs and symptoms include:

• Fever, night sweats, and unexplained weight loss
• Muscle and joint pain (myalgia and arthralgia)
• Abdominal pain, nausea, and vomiting (due to gastrointestinal involvement)
• Neurological symptoms, such as numbness, tingling, or weakness (due to nerve involvement)
• Kidney involvement, leading to hypertension and renal failure
• Skin manifestations, such as rashes, nodules, or ulcers

Source: Polyarteritis Nodosa – StatPearls – NCBI Bookshelf

Diagnostic Criteria

The diagnosis of periarteritis nodosa is based on a combination of clinical findings, laboratory tests, imaging studies, and histopathological examination of affected tissues. Some key diagnostic tests and criteria include:

• Blood tests: Elevated erythrocyte sedimentation rate ( ESR), C-reactive protein (CRP), and leukocytosis may be observed.
• Imaging studies: Angiography, computed tomography (CT), and magnetic resonance imaging (MRI) can help visualize vascular lesions and organ involvement.
• Tissue biopsy: Histopathological examination of affected blood vessels or tissues can confirm the presence of necrotizing vasculitis and support the diagnosis.
• Differential diagnosis: Other forms of vasculitis, autoimmune diseases, and infectious conditions must be ruled out.

Source: Epidemiology and Pathogenesis of Polyarteritis Nodosa – PMC

Associated Conditions

Periarteritis nodosa can be associated with or occur in conjunction with other conditions, including:

• Other forms of vasculitis, such as granulomatosis with polyangiitis (GPA) or eosinophilic granulomatosis with polyangiitis (EGPA)
• Autoimmune diseases, such as rheumatoid arthritis or systemic lupus erythematosus (SLE)
• Hepatitis B or C virus infections

Source: Polyarteritis Nodosa – StatPearls – NCBI Bookshelf

Complications

Periarteritis nodosa can lead to various complications due to the involvement of multiple organ systems and the damage caused by vascular inflammation and necrosis. Some potential complications include:

• Organ damage: Kidney failure, heart problems, gastrointestinal complications, and neurological deficits can occur due to vascular insufficiency and tissue ischemia.
• Aneurysms and infarctions: The weakening of blood vessel walls can lead to the formation of aneurysms, which can rupture and cause internal bleeding, or infarctions (tissue death due to lack of blood supply).
• Chronic disability and reduced quality of life: The multisystemic nature of the disease and potential organ damage can result in chronic debilitating symptoms and impaired function.

Source: Polyarteritis Nodosa – StatPearls – NCBI Bookshelf

Treatment

The treatment of periarteritis nodosa typically involves a combination of medications and supportive care. The main goals of treatment are to control symptoms, induce remission, and prevent complications. Treatment strategies may include:

• Corticosteroids: High-dose corticosteroids, such as prednisone, are often used to reduce inflammation and suppress the immune system.
• Immunosuppressive agents: Medications like cyclophosphamide, azathioprine, or methotrexate may be used in combination with corticosteroids to control the disease and maintain remission.
• Symptomatic management: Treatments for specific symptoms, such as pain relief, blood pressure control, or management of organ-specific complications, may be necessary.
• Supportive care: Close monitoring, physical therapy, and lifestyle modifications may be recommended to manage the disease and its impact on daily life.

Source: Epidemiology and Pathogenesis of Polyarteritis Nodosa – PMC

Prognosis

The prognosis of periarteritis nodosa can vary depending on various factors, such as the extent of organ involvement, the severity of the disease, and the response to treatment. With early diagnosis and appropriate treatment, many patients can achieve remission and manage their symptoms effectively. However, in some cases, the disease can be severe and potentially life-threatening, particularly if complications such as organ failure or aneurysm rupture occur.

Source: Polyarteritis Nodosa – StatPearls – NCBI Bookshelf